Charitable organizations are seeing more and more patients who need financial assistance, said Dan Klein, President and CEO, Patient Access Network (PAN) Foundation.
Charitable organizations are seeing more and more patients who need financial assistance, said Dan Klein, President and CEO, Patient Access Network (PAN) Foundation.
Transcript
More people are getting insurance, but plans are also shifting more financial burden to patients. Have changes like these resulted in any changes that you’ve seen from your end of providing financial assistance to patients?
We’re seeing more and more patients with high-deductible plans and more patients in Medicare who are reaching the catastrophic threshold. And, as a result, we’re seeing more demand for the types of grants and assistance that we provide. The numbers just seem to grow every year, and it’s a challenge to keep up.
We mainly serve Medicare patients—so about 85% to 90% of the patients we serve are on Medicare. As a result of the Affordable Care Act rolling out, obviously more people did get coverage, but those aren’t really the people who generally come to us for grants. Now, what’s potentially change is, one, people are coming off the Affordable Care Act coverage because of the changes that the new administration has put in place and, also, there’s this new emerging trend of something called accumulator adjusters that may make manufacturer coupons less useful for patients with commercial coverage. So those patients might start to look to charitable foundations like PAN for assistance. So, we could see an increase as a result of that.
Research Shows Prior Authorization Denials Delay Critical Immunology Care
May 10th 2024Results featured at the Academy of Managed Care Pharmacy 2024 annual meeting revealed a pattern of prior authorization rejections that could delay necessary therapeutic treatments for various patient groups.
Read More
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More